-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IumhnohnnoTbOilo+w/L51X7Dhq4RzMjc1gpc5ubgsRnMPZBXW/MWY6XZoluYF7Y Qu2PadPMBL89HW/2hIBPfA== 0001005477-03-003554.txt : 20030822 0001005477-03-003554.hdr.sgml : 20030822 20030822211259 ACCESSION NUMBER: 0001005477-03-003554 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20021004 FILED AS OF DATE: 20030822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACANE SCOTT CENTRAL INDEX KEY: 0001160291 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 03863482 BUSINESS ADDRESS: STREET 1: C/O HIGHLINE MANAGEMENT LLC STREET 2: 888 SEVENTH AVE CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2126032600 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DURUS CAPITAL MANAGEMENT CENTRAL INDEX KEY: 0001166014 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 03863483 BUSINESS ADDRESS: STREET 1: 113 POST RD. EAST CITY: VESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 2033410667 MAIL ADDRESS: STREET 1: 113 POST RD. EAST CITY: WESTPORT STATE: CT ZIP: 06880 3 1 edgar123.xml FORM 3 X0201 3 2002-10-04 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001166014 DURUS CAPITAL MANAGEMENT 113 POST RD. EAST WESTPORT CT 06880 0 0 1 0 0001160291 SACANE SCOTT 0 0 1 0 Common Stock 2291180 I See Footnote This Form 3 is being filed by the undersigned and by the individual listed on the exhibit to this Form 3 (the "Reporting Persons"). The amount shown in Column 2 of Table I reflects amounts beneficially owned by Durus Capital Management, LLC ("Capital") (and by Scott Sacane through Capital) pursuant to Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act") as of the date indicated in Item 2 above. Each of the Reporting Persons disclaims beneficial ownership over such securities for purposes of Section 16 of the Exchange Act except to the extent of their indirect pecuniary interest in such securities. Through Durus Life Sciences Master Fund Ltd. /s/ Scott Sacane 2003-08-22 EX-99 3 ex99.txt INFORMATION REGARDING JOINT FILERS Exhibit 99 Information Regarding Joint Filers Designated Filer of Form 3: Durus Capital Management, LLC Date of Event Requiring Statement: October 4, 2002 Issuer Name and Ticker Symbol: Guilford Pharmaceuticals Inc. (GLFD) Joint Filer Names and addresses: Scott Sacane, 20 Marshall Street, Suite 320, South Norwalk, CT 06854 Signatures: Durus Capital Management, LLC By: /s/ Scott Sacane ------------------------- Name: Scott Sacane Title: Managing Member /s/ Scott Sacane - ---------------------------------- Scott Sacane -----END PRIVACY-ENHANCED MESSAGE-----